BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2010
View Archived Issues
Preclinical and early clinical data reported on BC-3781
Read More
Extended proof-of-concept and drug interaction studies complete for IDX-899
Read More
Eisai details in vitro and in vivo activity of new antifungal E-1210
Read More
Researchers claim new glucokinase activators
Read More
SEPS Pharma presents new fluconazole prodrugs for fungal infections
Read More
Stemsynergy Therapeutics claims new Wnt signaling inhibitors
Read More
Deakin University presents new antibacterial agents
Read More
CH-14.18 shows promise in phase III trial in neuroblastoma
Read More
MV-062926 is active in mouse model of COPD
Read More
FDA accepts Accera's IND application for phase II/III AC-1204 trial in AD
Read More
NCI and Lixte Biotechnology collaborate on anticancer agent LB-100
Read More
ISTO Technologies' phase I trial of NuQu in discogenic back pain fully enrolled
Read More
NeuroSearch patents new voltage-gated K(V)7 potassium channel modulators
Read More
Roche buys rights to hepatitis C therapy danoprevir from InterMune
Read More
Sirius Genomics receives NRC-IRAP funding for discovery of genomic biomarkers
Read More
NIH funds Profectus BioSciences to develop HIV vaccine
Read More
Bepotastine besilate nasal spray is efficacious in allergic rhinitis
Read More
Sucampo submits marketing application for Amitiza in Japan
Read More
Xeomin launched in U.S. for cervical dystonia and blepharospasm
Read More
Pfizer acquires FoldRx Pharmaceuticals
Read More
FDA agrees to SPA for phase III Estybon trial in myelodysplastic syndromes
Read More
Recruitment complete in phase II tideglusib trial in progressive supranuclear palsy
Read More
DynPort Vaccine begins phase IIb trial of recombinant plague vaccine
Read More
ChemGenex completes pre-NDA meeting with FDA for Omapro
Read More
Neoprobe completes Lymphoseek pre-NDA meeting
Read More